Patent ID: 11911381
Assignee: SUMITOMO PHARMA CO. LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 6:
7. 2-[(4-{7-[(1S,3S,4R,6R)-6-(Cyclopropylmethyl)-2-azabicyclo[2.2.2]octane-3-carbonyl]-2,7-diazaspiro[3.5]nonan-2-yl}pyrimidin-5-yl)oxy]-5-fluoro-N,N-di(propan-2-yl)benzamide dihydrochloride in crystal form of form III which is characterized by a powder x-ray diffraction pattern having diffraction angle (2θ°) peaks of 4.3°±0.2°, and 7.0°±0.2°.